» Articles » PMID: 27335871

Opioid Mechanism Involvement in the Synergism Produced by the Combination of Diclofenac and Caffeine in the Formalin Model

Overview
Journal ISRN Pain
Date 2016 Jun 24
PMID 27335871
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Analgesics can be administered in combination with caffeine for improved analgesic effectiveness in a process known as synergism. The mechanisms by which these combinations produce synergism are not yet fully understood. The aim of this study was to analyze whether the administration of diclofenac combined with caffeine produced antinociceptive synergism and whether opioid mechanisms played a role in this event. The formalin model was used to evaluate the antinociception produced by the oral administration of diclofenac, caffeine, or their combination. Opioid involvement was analyzed through intracerebroventricular (i.c.v.) administration of naloxone followed by the oral administration of the study drugs. Diclofenac presented a dose-dependent effect, with a mean effective dose (ED50) of 6.7 mg/kg. Caffeine presented an analgesic effect with a 17-36% range. The combination of subeffective doses of each of the two drugs presented the greatest synergism with an effect of 57.7 ± 5.6%. The maximal antinociceptive effect was obtained with the combination of 10.0 mg/kg diclofenac and 1.0 mg/kg of caffeine, with an effect of 76.7 ± 5.6%. The i.c.v. administration of naloxone inhibited the effect of diclofenac, both separately and combined. In conclusion, caffeine produces antinociceptive synergism when administered in combination with diclofenac, and this synergism is partially mediated by opioid mechanisms at the central level.

Citing Articles

Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages.

Ialongo D, Tudino V, Arpacioglu M, Messore A, Patacchini E, Costi R Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242514 PMC: 10224171. DOI: 10.3390/ph16050730.


Pharmacokinetics and Pharmacodynamics of (S)-Ketoprofen Co-Administered with Caffeine: A Preclinical Study in Arthritic Rats.

Medina-Lopez R, Vara-Gama N, Soria-Arteche O, Moreno-Rocha L, Lopez-Munoz F Pharmaceutics. 2018; 10(1).

PMID: 29373537 PMC: 5874833. DOI: 10.3390/pharmaceutics10010020.

References
1.
Pinardi G, Sierralta F, Miranda H . Adrenergic mechanisms in antinociceptive effects of non steroidal anti-inflammatory drugs in acute thermal nociception in mice. Inflamm Res. 2002; 51(5):219-22. DOI: 10.1007/pl00000296. View

2.
Bjorkman R, Hedner J, Hedner T, Henning M . Central, naloxone-reversible antinociception by diclofenac in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1990; 342(2):171-6. DOI: 10.1007/BF00166960. View

3.
Ortiz M, Torres-Lopez J, Castaneda-Hernandez G, Rosas R, Vidal-Cantu G, Granados-Soto V . Pharmacological evidence for the activation of K(+) channels by diclofenac. Eur J Pharmacol. 2002; 438(1-2):85-91. DOI: 10.1016/s0014-2999(02)01288-8. View

4.
Sawynok J, Reid A, Doak G . Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: involvement of noradrenergic mechanisms. Pain. 1995; 61(2):203-213. DOI: 10.1016/0304-3959(94)00169-F. View

5.
Hoyo-Vadillo C, Garcia I, Villalon C, Terron J, Lopez-Munoz F . Relationship between plasma levels of naproxen and analgesic efficacy in rats: synergism with caffeine. Proc West Pharmacol Soc. 1994; 37:91-2. View